# Shiromitsu Tea (Camellia sinensis)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/shiromitsu-tea
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-31
**Evidence Score:** 2 / 10
**Category:** Tea
**Also Known As:** Camellia sinensis var. Shiromitsu, White Tea Shiromitsu Cultivar, Shiromitsu White Tea, East Asian White Tea Variant, Minimally Processed Camellia sinensis

## Overview

Shiromitsu Tea is a cultivar of Camellia sinensis prized for its exceptionally high catechin content, particularly epigallocatechin gallate (EGCG), ranging from 117 to 442 mg/L. These polyphenols exert antioxidant effects by scavenging [reactive oxygen species](/ingredients/condition/antioxidant) and inhibiting [digestive enzyme](/ingredients/condition/gut-health)s such as α-glucosidase and α-amylase to potentially modulate postprandial [blood glucose](/ingredients/condition/weight-management).

## Health Benefits

• [Antioxidant activity](/ingredients/condition/antioxidant) through catechin content (117-442 mg/L EGCG) - mechanism documented but no clinical trials specific to Shiromitsu
• Potential blood sugar regulation via α-glucosidase and α-amylase inhibition - preliminary evidence from related tea flower extracts
• Traditional digestive support - historical use documented over 2,000 years but no modern clinical validation
• Possible [cardiovascular](/ingredients/condition/heart-health) benefits from polyphenol content - evidence limited to general C. sinensis studies, not Shiromitsu-specific
• Detoxification support - traditional claim without clinical evidence for this cultivar

## Mechanism of Action

EGCG and related catechins in Shiromitsu Tea neutralize [reactive oxygen species](/ingredients/condition/antioxidant) by donating hydrogen atoms and chelating redox-active metal ions, reducing oxidative stress at the cellular level. These catechins competitively inhibit α-glucosidase and α-amylase, slowing carbohydrate hydrolysis and attenuating postprandial glucose spikes through reduced intestinal glucose absorption. Additionally, tea flower-derived polyphenols from Camellia sinensis have been shown to modulate NF-κB signaling pathways, contributing to [anti-inflammatory](/ingredients/condition/inflammation) effects that may support gastrointestinal mucosal integrity.

## Clinical Summary

No randomized controlled trials have been conducted specifically on the Shiromitsu cultivar; available evidence is extrapolated from broader Camellia sinensis research and in vitro studies on related tea flower extracts. In vitro enzyme inhibition assays demonstrate significant α-glucosidase inhibition (IC50 values in the range of 0.5–2.0 mg/mL for green tea catechin fractions), though these findings have not been validated in Shiromitsu-specific human trials. General green tea clinical trials involving 100–1,000 mg/day EGCG have shown modest reductions in fasting [blood glucose](/ingredients/condition/weight-management) (approximately 5–7%) and improvements in [antioxidant](/ingredients/condition/antioxidant) biomarkers in populations with metabolic syndrome, but direct application to Shiromitsu remains speculative. The evidence base for this cultivar specifically is preliminary, and robust human clinical data are needed before definitive health claims can be made.

## Nutritional Profile

Shiromitsu Tea (Camellia sinensis tea flower/bud preparation) contains minimal macronutrients per brewed serving: negligible protein (<0.1g/100mL), negligible fat (<0.05g/100mL), and trace carbohydrates (<0.5g/100mL). Primary bioactive compounds include catechins at 117-442 mg/L total, with EGCG (epigallocatechin gallate) as the dominant fraction (typically 50-60% of total catechins), EGC (epigallocatechin), ECG (epicatechin gallate), and EC (epicatechin). Caffeine content is estimated at 20-40 mg per 200mL serving, lower than standard green tea (40-70mg) due to tea flower sourcing. Theanine (L-theanine) present at approximately 5-10 mg/100mL, contributing to umami character. Flavonols including quercetin, kaempferol, and myricetin glycosides present in trace amounts (1-5 mg/L total). Polyphenol bioavailability is moderate: catechins exhibit 20-30% intestinal absorption, enhanced in fasted state and reduced by milk proteins. Minerals include trace fluoride (~0.1-0.3 mg/100mL), manganese (~0.1-0.5 mg/100mL), and potassium (~10-20 mg/100mL). Vitamin C content is minimal post-brewing (<1 mg/100mL due to heat degradation). Chlorophyll derivatives (if any leaf content present) at <1 mg/100mL. Note: Specific Shiromitsu varietal concentration data is limited; values extrapolated from Camellia sinensis flower and green tea literature.

## Dosage & Preparation

No clinically studied dosage ranges are available for Shiromitsu Tea. General C. sinensis standardization often targets 30-42% catechin content, but no Shiromitsu-specific protocols exist. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Shiromitsu Tea is generally well tolerated at typical dietary consumption levels, but concentrated EGCG supplements exceeding 800 mg/day have been associated with hepatotoxicity, nausea, and elevated liver enzymes in case reports and clinical observations. Catechins can reduce iron absorption by forming insoluble complexes with non-heme iron, making high-dose use a concern for individuals with iron-deficiency anemia. EGCG may interact with anticoagulants such as warfarin by inhibiting platelet aggregation, and may reduce the bioavailability of certain beta-blockers and statins through CYP3A4 modulation. Pregnant and breastfeeding individuals should limit intake due to caffeine content and theoretical risks of high-dose polyphenol exposure to fetal development.

## Scientific Research

No specific clinical trials, RCTs, or meta-analyses were identified for Shiromitsu Tea as a distinct cultivar. Available research focuses on compositional analysis (PMID: 17899383) and general Camellia sinensis chemistry rather than clinical outcomes.

## Historical & Cultural Context

Camellia sinensis cultivars have been used in Traditional Chinese Medicine for over 2,000 years for [digestion](/ingredients/condition/gut-health), detoxification, and [longevity](/ingredients/condition/longevity). White tea variants emerged in Fujian Province, China, valued for minimal processing to retain vital energies (qi) according to TCM principles.

## Synergistic Combinations

Green tea extract, L-theanine, vitamin C, quercetin, resveratrol

## Frequently Asked Questions

### How much EGCG does Shiromitsu Tea contain compared to regular green tea?

Shiromitsu Tea contains between 117 and 442 mg/L of EGCG depending on brewing conditions and harvest timing, which can be significantly higher than typical commercial green teas that average 50–150 mg/L. This elevated catechin concentration makes Shiromitsu particularly potent as a source of polyphenolic antioxidants relative to standard Camellia sinensis cultivars.

### Can Shiromitsu Tea help lower blood sugar levels?

Preliminary in vitro evidence suggests that catechins from Camellia sinensis tea flower extracts, closely related to Shiromitsu, inhibit α-glucosidase and α-amylase with IC50 values in the range of 0.5–2.0 mg/mL, which would theoretically slow post-meal glucose absorption. However, no human clinical trials have been conducted specifically on Shiromitsu Tea for glycemic control, so these effects remain unconfirmed in people and should not replace prescribed diabetes management.

### What is the recommended daily intake of Shiromitsu Tea?

No cultivar-specific dosage guidelines exist for Shiromitsu Tea; general guidance derived from green tea research suggests 2–4 cups per day (providing roughly 200–400 mg of total catechins) is considered safe and potentially beneficial. EGCG supplement doses above 800 mg/day have been linked to adverse liver effects, so whole-leaf tea consumption is generally preferred over concentrated extracts for long-term use.

### Does Shiromitsu Tea interact with any medications?

EGCG in Shiromitsu Tea can inhibit CYP3A4 enzyme activity, potentially increasing plasma concentrations of drugs metabolized by this pathway, including certain statins, calcium channel blockers, and immunosuppressants. Additionally, catechins may potentiate the anticoagulant effects of warfarin and aspirin by inhibiting platelet aggregation, so individuals on blood-thinning medications should consult a healthcare provider before regular high-dose consumption.

### Is Shiromitsu Tea safe during pregnancy?

Shiromitsu Tea contains caffeine (typically 20–45 mg per 8 oz cup for green tea cultivars), and current obstetric guidelines recommend limiting total caffeine intake to under 200 mg/day during pregnancy. High-dose EGCG supplementation also carries theoretical risks to fetal folate metabolism, so pregnant individuals should stick to no more than 1–2 cups of brewed Shiromitsu Tea daily and avoid concentrated catechin supplements entirely.

### What makes Shiromitsu Tea different from other Camellia sinensis varieties in terms of catechin composition?

Shiromitsu Tea is a shade-grown cultivar of Camellia sinensis that develops distinct catechin profiles due to reduced sunlight exposure during cultivation, which alters chlorophyll and amino acid metabolism compared to sun-grown green teas. This processing method can influence the relative concentrations of EGCG and other polyphenols within the documented range of 117-442 mg/L EGCG. The shade-growing technique is similar to methods used for gyokuro and matcha, creating a unique phytochemical composition specific to this cultivar variant.

### Is there clinical research evidence specifically validating Shiromitsu Tea's traditional digestive health claims?

While Shiromitsu Tea has a documented history of traditional digestive support spanning over 2,000 years, modern clinical trials specifically evaluating this cultivar for digestive benefits have not been published. Related studies on tea flower extracts and other Camellia sinensis varieties suggest potential mechanisms through enzyme inhibition, but these findings cannot be directly attributed to Shiromitsu Tea without dedicated human studies. Consumers should distinguish between traditional historical use and evidence-based clinical validation when considering this ingredient for digestive purposes.

### Who would benefit most from Shiromitsu Tea supplementation based on current evidence?

Individuals seeking antioxidant support through catechin-rich beverages may benefit from Shiromitsu Tea, as its documented EGCG content aligns with established antioxidant mechanisms in Camellia sinensis species. Those interested in traditional digestive or cardiovascular applications should recognize that benefits remain supported by historical use rather than modern clinical validation for this specific cultivar. People sensitive to caffeine should note that Shiromitsu Tea contains naturally occurring caffeine comparable to standard green tea varieties.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*